BeStock  

Regencell Bioscience RGC

US equityMarket cap rank #2658Drug Manufacturers - Specialty & Generic
$4.18 −$0.18 (-4.13%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.18 0.00%
Open$4.43
Prev close$4.36
Day range$4.12 – $4.43
Volume111.1K
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RGC at a glance

Regencell Bioscience stock (RGC) sits at $4.18, down 4.13% today. The business is worth $2.07B in the market, good for #2658 of 3753 on our coverage list.

It is close to the bottom of its 52-week range ($4.12 to $69.00), 93.9% under the high. Holders are behind 66.5% over twelve months, and down 21.0% across the last three months.

On the chart it has slipped under both the 50-day ($6.63) and 200-day ($15.42) moving averages; RSI is 30, and the last 30 sessions moved at roughly 128% annualized volatility.

For the quarter ended Dec 2017 it reported $861.60M in revenue, up 6.0% from a year earlier, with $28.90M of net profit (a 3.4% margin).

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$4.10 / $4.18
Average price today$4.25
Volume111.1KAvg (90d) 226.0K
Turnover$471,884.00
Turnover rate0.20%of shares outstanding
Volume ratio1.14vs. recent average pace
Day amplitude7.11%
Market cap$2.07B
Float market cap$235.72M
Shares outstanding56.39M
EPS (TTM)-$0.02
P/B154.81
Book value / share$0.03
Net profit (TTM)-$11.90M
Net assets$13.39M
30-day volatility127.8%annualized
Avg daily range (ATR)12.44%of price, 14 days
Max drawdown (1y)-92.1%-92.1% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

F
BeStock Grade

Composite of 2 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 7.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth24.8
Profitability28.8
Momentum5.0
Financial health86.1
Analyst view—

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Morningstar fair value$5.47Price is below fair value

Morningstar’s fair value model puts the stock at $5.47, so shares trade 23.5% below that estimate. On earnings multiple, it sits in the 41st percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.1%
1 week
-15.4%
1 month
-57.4%
3 months
-21.0%
6 months
-83.8%
Year to date
-80.1%
1 year
-66.5%
Day range
$4.12$4.43
52-week range
$4.12$69.00

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-25.5%Bearish
Price vs 50-day average-36.9%Bearish
Price vs 200-day average-72.9%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)30.3Bearish
MACD (12,26,9)-0.78Bearish
Bollinger band position14%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RGC ranks on BeStock

Market value#2647 of 3734
Closeness to 52-week high#3715 of 3724
Dollar volume today#3004 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RGC is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RGC.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RGC

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RGC stock: common questions

What is RGC's latest share price?

$4.18 is the latest print for RGC, a move of -4.13% against yesterday's close of $4.36. Today's low and high so far: $4.12 and $4.43.

How large is Regencell Bioscience by market value?

Equity value comes to $2.07B at the current price. By that measure it is number 2658 of the 3753 names in our coverage.

Where does RGC sit in its 52-week range?

The year's floor is $4.12 and the ceiling $69.00. Shares are 93.9% away from that ceiling.

Does RGC send cash back through a dividend?

Our data shows no dividend paid by Regencell Bioscience over the trailing twelve months.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RGC.

Sign in to join the discussion.

Scroll to Top